Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Participants who experienced any adverse event Adverse event regardless of severity · people with drug‐resistant focal epilepsy

Carisbamate showed no clear difference in proportion of participants who experienced atleast 1 adverse event compared with placebo (low certainty).

1 finding from 1 review

Carisbamate add‐on therapy for drug‐resistant focal epilepsy 2021 · Cochrane Headline outcomes only
RR 1.1 [0.93, 1.3]
2 studies · 1084 participants
Low